HealthCare Ventures

Total investments

108

Average round size

23M

Portfolio companies

56

Rounds per year

2.77

Lead investments

12

Follow on index

0.48

Exits

33

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsGeneticsMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

HealthCare Ventures is the famous VC, which was founded in 1985. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Cambridge.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the HealthCare Ventures, startups are often financed by MPM Capital, Amgen Ventures, Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are Rho Ventures, Novartis Venture Fund, New Enterprise Associates. In the next rounds fund is usually obtained by Oxford Bioscience Partners, MPM Capital, Morgenthaler Ventures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Genetics, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Senseonics, Catalyst Biosciences, TetraLogic Pharmaceuticals. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 deals per year. The real fund results show that this VC is 3 percentage points more often commits exit comparing to other companies. Comparing to the other companies, this HealthCare Ventures performs on 1 percentage points more the average number of lead investments. The top activity for fund was in 2011. The higher amount of exits for fund were in 2016. When the investment is from HealthCare Ventures the average startup value is 10-50 millions dollars.

The current fund was established by Harold Werner. We also calculated 6 valuable employees in our database.

Show more

Investments analytics

Analytics

Total investments
108
Lead investments
12
Exits
33
Rounds per year
2.77
Follow on index
0.48
Investments by industry
  • Biotechnology (97)
  • Health Care (74)
  • Medical (41)
  • Pharmaceutical (40)
  • Therapeutics (28)
  • Show 31 more
Investments by region
  • United States (101)
  • United Kingdom (2)
  • Australia (2)
Peak activity year
2011
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
37M
Group Appearance index
0.92
Avg. company exit year
9
Avg. multiplicator
1.54
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ActivBiotics 10 Jan 2002 Health Care, Medical, Therapeutics Early Stage Venture 17M United States, Massachusetts
Proteostasis Therapeutics 08 Sep 2015 Biotechnology, Medical, Therapeutics Early Stage Venture 37M United States, Massachusetts, Cambridge

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.